Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    LENZ Therapeutics Inc.

    NASDAQ: LENZ · Real-Time Price · USD
    30.18
    0.07 (0.23%)
    At close: Jun 27, 2025, 3:59 PM
    29.65
    -1.76%
    After-hours: Jun 27, 2025, 05:11 PM EDT

    LENZ Therapeutics Statistics

    Share Statistics

    LENZ Therapeutics has 28.15M shares outstanding. The number of shares has increased by 7.87% in one year.

    Shares Outstanding

    n/a
    		 28.15M

    Shares Change (YoY)

    n/a
    		 7.87%

    Shares Change (QoQ)

    n/a
    		 0.15%

    Owned by Institutions (%)

    n/a
    		 71.26%

    Shares Floating

    n/a
    		 21.79M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,262

    FTD / Avg. Volume

    n/a
    		 0.48%

    Short Selling Information

    The latest short interest is 3.33M, so 11.84% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 3.33M

    Short % of Shares Out

    n/a
    		 11.84%

    Short % of Float

    n/a
    		 22.18%

    Short Ratio (days to cover)

    n/a
    		 23.88

    Valuation Ratios

    The PE ratio is -12.34 and the forward PE ratio is -10.79. LENZ Therapeutics's PEG ratio is 0.15.

    PE Ratio

    n/a
    		 -12.34

    Forward PE

    n/a
    		 -10.79

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 2.5

    PB Ratio

    n/a
    		 3.01

    P/FCF Ratio

    n/a
    		 -10.26

    PEG Ratio

    n/a
    		 0.15
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for LENZ Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 20.36, with a Debt / Equity ratio of 0.01.

    Current Ratio

    n/a
    		 20.36

    Quick Ratio

    n/a
    		 20.36

    Debt / Equity

    n/a
    		 0.01

    Debt / EBITDA

    n/a
    		 -0.03

    Debt / FCF

    n/a
    		 -0.02

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-8,294,833.33

    Employee Count

    n/a
    		 6

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 1K

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by 69.34% in the last 52 weeks. The beta is 0.41, so LENZ Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.41

    52-Week Price Change

    n/a
    		 69.34%

    50-Day Moving Average

    n/a
    		 28.22

    200-Day Moving Average

    n/a
    		 27.05

    Relative Strength Index (RSI)

    n/a
    		 54.69

    Average Volume (20 Days)

    n/a
    		 263,972

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 -58K

    Operating Income

    n/a
    		 -58.61M

    Net Income

    n/a
    		 -49.77M

    EBITDA

    n/a
    		 -49.71M

    EBIT

    n/a
    		 -49.77M

    Earnings Per Share (EPS)

    n/a
    		 -2.34
    Full Income Statement

    Balance Sheet

    The company has 20.16M in cash and 1.38M in debt, giving a net cash position of 18.78M.

    Cash & Cash Equivalents

    n/a
    		 20.16M

    Total Debt

    n/a
    		 1.38M

    Net Cash

    n/a
    		 18.78M

    Retained Earnings

    n/a
    		 -145.01M

    Total Assets

    n/a
    		 201.25M

    Working Capital

    n/a
    		 189.29M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -59.39M and capital expenditures -468K, giving a free cash flow of -59.86M.

    Operating Cash Flow

    n/a
    		 -59.39M

    Capital Expenditures

    n/a
    		 -468K

    Free Cash Flow

    n/a
    		 -59.86M

    FCF Per Share

    n/a
    		 -2.81
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    LENZ does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for LENZ is $42.5, which is 40.9% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $42.5

    Price Target Difference

    n/a
    		 40.9%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 4
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Mar 22, 2024. It was a backward split with a ratio of 1:7.

    Last Split Date

    n/a
    		 Mar 22, 2024

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:7

    Scores

    Altman Z-Score

    n/a
    		 53.32

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist